The risk of unintended consequences with genetic modification has a potential to create new defects and/or disease.
Robert Aderholt
The Public Record
Robert Brown Aderholt is a Republican member of the United States House of Representatives, representing Alabama's 4th congressional district since 1997. Born on July 22, 1966, Aderholt has been a prominent figure in Alabama politics for over two decades. He has served on various committees, including the Appropriations Committee, where he has focused on issues such as agriculture, education, and national security. Aderholt is known for his conservative positions and has been an advocate for policies that support rural communities in Alabama.
So when do you anticipate making a final determination on whether to move forward with this rule?
The cost of drugs is a very real concern I think that the American public is concerned about.
How can the administration tell the public they are concerned about rising cost of prescription drugs on one hand, and then on the other finalize a rule that could add another $4 billion to the cost of prescription drugs?
I commend you for that, and as a cancer survivor, I certainly appreciate the elimination or the proposed elimination of all of the silos that have slowed down the collaboration.
Without objection, I have got a letter that I would like to submit for the record.
I think the concern is probably China. And do we have different standards in place for places like China than we do in the United States?
We have seen some situations in the past where the administrations in the past have decided to release controversial, unpopular regulations in the last few months of an administration that is not returning to power.
Premium cigars have also been an issue. It does not have that youth access issue.
I am concerned, and I think many are concerned that some parts of the administration have not done enough to get in front of this debate.
But if GMO products are safe, then my question would be: why are FDA or even sister agencies not doing more to educate the consumers that these products are perfectly safe?
I want to say thank you for your work. In your interim time at FDA, you have been certainly a pleasure to work with.
I think the bottom line is trying to find a better--to make sure the taxpayers' dollar is protected.
I think it is imperative that you conduct an independent study and review--and your review include all the development of the risk factors known to the industry.
We have an ever-shrinking pot of money for infrastructure improvement, and we are spreading it out way, way thin.
I would like to hear in particular today how your Department is protecting Americans' second amendment rights...
I think what needs to be said is the research is very important, as 11 western States and the community farmers and ranchers industry and our Federal agencies are trying to avoid the listing of the sage-grouse under the Endangered Species…
I think they are totally ineffective, and I think this article brought it out, that they missed the mark on this.
Have you investigated the specific instance of the animal abuse that is mentioned in the article?
The Congress that puts those caps on can be the Congress that takes those caps off.
I am completely opposed to the Executive actions issued by memo under your signature last December.
This is a troubling development that could severely hurt the growth and surplus in U.S. agricultural exports.
I do not propose that in any way that our international food programs need to be cut.
So let's come up with a new trade paradigm that ensures that American workers, American farmers, come out the winners and can participate in the global market on that basis.





